• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE

RECCE PHARMACEUTICALS LTD - Corporate Spotlight

6.82% ! 41.0¢
Market Cap $118.5M  !

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

US DEFENCE GRANTS EYED FOR R327 BURN WOUND DATA
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
41.0¢
Change
-0.030(6.82%)
Mkt cap ! $118.5M
Open High Low Value Volume
44.5¢ 44.5¢ 40.5¢ $302.0K 718.0K

Buyers (Bids)

No. Vol. Price($)
2 36975 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 10422 1
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
Last
41.0¢
  Change
-0.030 ( 6.82 %)
Open High Low Volume
44.0¢ 44.5¢ 40.5¢ 332183
Last updated 15.57pm 11/09/2025 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.